These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1345691)

  • 1. [Immunotherapy of severe infectious states].
    Offenstadt G; Guidet B; Lazard T
    Chirurgie; 1992; 118(10):601-6. PubMed ID: 1345691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic perspectives of severe infectious states].
    Offenstadt G; Guidet B; Barakett V
    Rev Prat; 1993 Jan; 43(1):59-64. PubMed ID: 8469900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines and immunotherapy in infectious diseases].
    van der Meer JW; Netea MG; Kullberg BJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2252-5. PubMed ID: 10578424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sepsis syndrome: progress and therapeutic perspectives].
    Schaller MD
    Schweiz Med Wochenschr; 1992 May; 122(20):768-75. PubMed ID: 1604283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of gram-negative sepsis.
    Dudley MN
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S3-6. PubMed ID: 2275477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines and severe infections].
    Offenstadt G; Guidet B; Staikowsky F
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):820-31. PubMed ID: 8309725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of sepsis syndrome: a comparison of the available treatments.
    Fisher CJ; Bellingan G
    Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of activin in bacterial infections: a potential target for immunointervention?
    Ebert S; Nau R; Michel U
    Immunotherapy; 2010 Sep; 2(5):673-84. PubMed ID: 20874651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF antibodies: lessons from the past, roadmap for the future.
    Shealy DJ; Visvanathan S
    Handb Exp Pharmacol; 2008; (181):101-29. PubMed ID: 18071943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.